Beyond the current HPV diagnosis
Clinically validated Seegene HPV assays
Complete solution for
HPV screening and genotyping
Anyplex™ II HPV HR and HPV28 Detection are designed to identify 14 and/or 28 different HPV types in a single specimen and fulfill all clinical requirements for the primary cervical cancer screening.
IPVC 2020 - NOW VIRTUAL
July 20-24, 2020 | Join us on-line
Continuous Challenge in cervical cancer screening: Beyond the current HPV diagnosis
Chair: Xavier Bosch (ICO, Spain)
Hugo Sousa (IPO, Portugal)
Clementina Elvezia Cocuzza (UNIMIB, Italy)
View video clips
Watch the videos that can show you the outstanding features and benefits of Seegene HPV assays.
Download brochures
Download the brochures for the results of various studies and detailed information of the Seegene HPV assays.
Excellent clinical performance in VALGENT-3 framework
The clinical performance of Anyplex™ II HPV HR Detection showed comparable outcomes with Hybrid Capture 2 HPV DNA test (HC2) and Cobas 4800 HPV test (Cobas) in VALGENT-3 study.
Reference - Ostrbenk et al. (2018) Journal of Clinical Microbiology
Fulfillment of international guidelines
Anyplex™ II HPV HR Detection fulfills the international consensus validation metrics for HPV DNA tests for cervical cancer screening.
Reference - Hessenlink AT et al. Journal of Clinical Virology (2016) 76:36-39, Meijer CJLM et al. Int J Cancer (2009)124(3):516~20
100% proficient results in the WHO HPV LabNet study
Anyplex™ II HPV28 Detection had 100% proficient results for HPV type detection from all participants in the WHO HPV LabNet international proficiency study.
Reference - Carina EKlund et al. Journal of Clinical Virology (2018) 101:74-85
Seegene's automation platform
Anyplex™II HPV HR and HPV28 Detection can be applied on Seegene's automation platform, which streamlines and optimizes the workflow of HPV genotyping and screening.
